I wrote about the cozy relationship between pharmaceutical companies and academics last month but now the subject is heating up in the New York Times.Here's how it works. Drug and device makers (think: joint replacements, pacemakers, heart stents) pay doctors and academic programs millions of dollars to collaborate in research, write scientific articles that always show the drug or device to be
No comments:
Post a Comment